Beryl Drugs informs about unaudited financial results

14 Mar 2018 Evaluate

Beryl Drugs has informed about resubmission of unaudited financial results for the quarter ended 30th June, 2017 as per schedule III of companies act, 2013.

The above information is a part of company’s filings submitted to BSE.

Beryl Drugs Share Price

30.00 0.38 (1.28%)
28-Mar-2024 14:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1624.10
Dr. Reddys Lab 6199.00
Cipla 1506.25
Zydus Lifesciences 1013.95
Lupin 1620.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.